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AVERAGE MAP
INDUCED HYPERTENSIVE HEART DISEASE
Figure 6. The PVC and arrhythmia were observed in both HTN Sham and HTN VNS rats after first 6
weeks on high salt diet. HTN VNS, but not HTN Sham, rats started to exhibit significantly decreased
frequency of the arrhythmias occurrence after 4 weeks of VNS.
ANIMAL MODEL 
Vagal nerve stimulators (Cyberonics Model 103, Houston, TX, USA) and DSI transmitters (HD-S11, DSI
Inc., MN, USA) implanted at the beginning of the study
Figure 5. Episodes of PVC and other arrhythmias were observed in rats after the 6 weeks of high salt diet as
shown. Typical examples of PVC (Fig. 5A, arrow) and arrhythmias (Fig 5B, skipping beats; Fig 5C, VT ) are shown
with the corresponding arterial blood pressure trace in the bottom
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Figure 4. Average MAP values for day time monitoring of VNS rats versus Sham rats
• Vagal nerve stimulation (VNS) can restore the autonomic nervous system balance
in the vascular system and in the heart to reduce risk of heart failure from
hypertension (HTN).
• The potential of VNS to be used as a novel device-based therapy for HTN and
HTN-induced heart diseases. The effect of VNS on mean arterial blood pressure
(MAP) and arrhythmogenesis in-vivo in a genetic model of hypertension was
studied.
Figure 3. 24 hour heart rate (HR) samples of VNS rats and Sham rats from 6AM to 6AM next day.
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In this study, we investigated the effects of VNS on arterial blood pressure and ECG 
during in-vivo experiments and the electrical properties of the rat hearts during 
periodic pacing and VT/VF. We investigated possible mechanisms underlying these 
effects.
Our results demonstrated two main findings. First, long term (more than 2 weeks) 
VNS reduced blood pressure and induced anti-arrhythmic effects. Second, These 
changes are not induced through the structure remodeling mechanism.  
Conclusions
Subjects used were dahl salt sensitive rats that was fed with high salt diet to induce 
hypertension
•Rats were randomly divided into 2 groups: HTN-Sham (n=6, with non-functional 
VNS stimulators) and HTN-VNS (n=6, with functional VNS stimulators). 
•Real time electrocardiography (ECG) and arterial blood pressure data were 
monitored in-vivo and compared 
•Functional vagal nerve stimulators were subdermally implanted in the HTN-VNS 
rats at the right cervical vagus nerve . 
•Pressure catheter was implanted into the descending aorta. The real time ECG 
and mean arterial blood pressure (MAP) data were collected with 500 Hz sample 
rate. 
4 WEEKS VNS (ECG) in vivo
Figure 7. The heart weight/tibia length ratio (HW/TL) and RV/LV wall thickness ratio measured showing no
induce a structural remodeling of the heart
EXPERIMENT TIMELINE
Figure 2. Shows the difference in small artifacts in the ECG recording when VNS stimulation is turned on.
VNS stimulation had no effects on the blood pressure recording .
Parameters:
•Frequency: 20 Hz
•Pulse width: 500 µsec
•Current: 1mA
•Duty Cycle: 12%
Results 
#
VNS STIMULATION 
Figure 1. Timeline of study that shows VNS was introduced in the subjects from week 7 to week 10.
# P< 0.05
